← All stocks

Larimar Therapeutics, Inc.

LRMR Net buying

CIK 0001374690 #3232 in the set updated 17 Sep 2026

Bought (12 mo)

$25.72M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$25.72M

+$25.72M against sales at will

By person

8 insiders · 8 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Flynn James E

Director

$25.00M (4)

—

+$25.00M

6,207,982

5.98%

$20.72M

—

Hamilton Thomas Edward

Director

$666.89K (2)

—

+$666.89K

714,798

0.6881%

$2.39M

+26.6%

SHERMAN JEFFREY W

Director

$25.00K (1)

—

+$25.00K

5,000

0.0048%

$16.69K

—

THOMAS FRANK E

Director

$25.00K (1)

—

+$25.00K

7,000

0.0067%

$23.36K

+250.0%

BEN-MAIMON CAROLE

President and CEO

—

368,276

0.3545%

$1.23M

+107.9%

Celano Michael

Chief Financial Officer

—

215,785

0.2077%

$720.25K

+49.9%

Shankar Gopi

Chief Development Officer

—

76,443

0.0736%

$255.15K

+178.0%

Clayton Russell

Chief Medical Officer

—

71,443

0.0688%

$238.46K

+217.5%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 15

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 2

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 188,978

History held since 31 Aug 2016